Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1975-12-09
1978-01-24
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
260112R, 260113, 260115, 195 68, A61K 3714, C07G 702, C07G 704
Patent
active
040704599
ABSTRACT:
N-carbamylated orgotein, like the native protein, possesses superoxide dismutase and anti-inflammatory activity.
REFERENCES:
patent: 3758682 (1973-09-01), Huber et al.
patent: 4017605 (1977-04-01), Huber et al.
patent: 4022888 (1977-05-01), Huber et al.
Chemical Modification of Proteins, Means & Feeney, pp. 70-71, 74-75, 82, 85, 86-87, 109, 142-143, 146, (1971).
Huber Wolfgang
Saifer Mark G.
Williams Lewis D.
Diagnostic Data, Inc.
Schain Howard E.
LandOfFree
N-carbamylated orgotein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-carbamylated orgotein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-carbamylated orgotein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-488801